...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Portal Vein Embolization before Right Hepatectomy or Extended Right Hepatectomy Using Sodium Tetradecyl Sulfate Foam: Technique and Initial Results
【24h】

Portal Vein Embolization before Right Hepatectomy or Extended Right Hepatectomy Using Sodium Tetradecyl Sulfate Foam: Technique and Initial Results

机译:在右肝切除术或右肝切除术前使用十四烷基硫酸钠泡沫进行门静脉栓塞:技术和初步结果

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To evaluate the safely and efficacy of portal vein embolization (PVE) with sodium tetradecyl sulfate (STS) foam. Materials and Methods: A single-center retrospective review of 35 patients (27 men and 8 women; mean age, 61 y) who underwent PVE with STS foam was performed. The technical success rate, rate of PVE at producing adequate future liver remnant (FLR) hypertrophy, and rate of disease progression precluding resection alter PVE were analyzed. Complications of PVE and liver resection after PVE were recorded. Results: PVE was performed on 35 patients before right hepatic resection for both primary and secondary hepatic malignancies (22 hepatoceilular carcinoma, 10 metastasis, 2 cholangiocarcinoma. 1 invasive gallbladder carcinoma). Technical success was achieved in 97.1'/! (34 of 35) of patients. Mean FLR of the total estimated licr volume increased from 24.5% (SD, 7.7%) to 36.5% (SD. 14.5%). a mean percentage increase of 48.8% (SD. 34.3%). PVE produced adequate FLR hypertrophy in 31 of 35 patients (88.6%). Proposed right hepatectomy was subsequently performed in 27 patients (77.1%). One patient remains scheduled for surgery, two had peritoneal spread at surgery and resection was aborted, two had disease progression on imaging after PVE. and three had inadequate FLR hypertrophy with no surgery. One major complication was observed related to PVE that involved nontargct embolization to segment III. which was managed conservatively. Conclusions: Preoperative PVE with STS foam is a safe and effecme method to induce hypertrophy of the FLR.
机译:目的:评估十四烷基硫酸钠(STS)泡沫对门静脉栓塞(PVE)的安全性和有效性。材料和方法:对35例行SVE泡沫PVE治疗的患者(27例男性和8例女性;平均年龄61岁)进行了单中心回顾性研究。分析了技术成功率,产生足够的未来肝残余(FLR)肥大的PVE率以及排除PVE切除后的疾病进展率。记录PVE的并发症和PVE后的肝切除。结果:35例右肝切除术前行原发性和继发性肝恶性肿瘤(22例肝小细胞癌,10例转移,2例胆管癌,1例浸润性胆囊癌)行PVE检查。技术上的成功达到了97.1'/! (35之34)患者。总估计生命的平均FLR从24.5%(SD,7.7%)增加到36.5%(SD。14.5%)。平均百分比增长48.8%(标准差34.3%)。 PVE在35例患者中有31例产生了足够的FLR肥大(88.6%)。随后对27例患者(77.1%)进行了建议的右肝切除术。一名患者仍按计划进行手术,两名患者在手术时腹膜扩散,切除手术中止,两名患者在PVE后影像学上发现疾病进展。三人的FLR肥大不足,没有进行手术。观察到与PVE有关的一项主要并发症,涉及非节段性栓塞至第III节。这是保守管理的。结论:术前用STS泡沫进行PVE是诱发FLR肥大的一种安全有效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号